PDGFRA and neoplasm: The distribution of PDGFRA mutant tumours between the low- and high-risk categories was significantly different from that of KIT mutant or wild-type tumours when using the AFIP classification (P=0.005, Kruskal–Wallis test), but not when using the NIH classification (P=0.452, Kruskal–Wallis test).